224 related articles for article (PubMed ID: 8752276)
21. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.
Tan RS; Taniguchi T; Harada H
Cancer Res; 1996 May; 56(10):2417-21. PubMed ID: 8625321
[TBL] [Abstract][Full Text] [Related]
22. In vitro transcriptional activation of p21 promoter by p53.
Kim TK
Biochem Biophys Res Commun; 1997 May; 234(2):300-2. PubMed ID: 9177263
[TBL] [Abstract][Full Text] [Related]
23. Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis.
Hellin AC; Bentires-Alj M; Verlaet M; Benoit V; Gielen J; Bours V; Merville MP
J Pharmacol Exp Ther; 2000 Dec; 295(3):870-8. PubMed ID: 11082419
[TBL] [Abstract][Full Text] [Related]
24. The apoptotic and transcriptional transactivation activities of p53 can be dissociated.
Bissonnette N; Wasylyk B; Hunting DJ
Biochem Cell Biol; 1997; 75(4):351-8. PubMed ID: 9493957
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
26. HiNF-D (CDP-cut/CDC2/cyclin A/pRB-complex) influences the timing of IRF-2-dependent cell cycle activation of human histone H4 gene transcription at the G1/S phase transition.
Aziz F; van Wijnen AJ; Stein JL; Stein GS
J Cell Physiol; 1998 Dec; 177(3):453-64. PubMed ID: 9808153
[TBL] [Abstract][Full Text] [Related]
27. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
Lee AH; Hong JH; Seo YS
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
[TBL] [Abstract][Full Text] [Related]
28. N-ras-induced growth suppression of myeloid cells is mediated by IRF-1.
Passioura T; Dolnikov A; Shen S; Symonds G
Cancer Res; 2005 Feb; 65(3):797-804. PubMed ID: 15705876
[TBL] [Abstract][Full Text] [Related]
29. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
Howard SP; Park SJ; Hughes-Davies L; Coleman CN; Price BD
Clin Cancer Res; 1996 Feb; 2(2):269-76. PubMed ID: 9816169
[TBL] [Abstract][Full Text] [Related]
30. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage.
Lestari W; Ichwan SJ; Otsu M; Yamada S; Iseki S; Shimizu S; Ikeda MA
Biochem Biophys Res Commun; 2012 Jan; 417(2):710-6. PubMed ID: 22172947
[TBL] [Abstract][Full Text] [Related]
31. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias.
Beretta L; Gabbay M; Berger R; Hanash SM; Sonenberg N
Oncogene; 1996 Apr; 12(7):1593-6. PubMed ID: 8622878
[TBL] [Abstract][Full Text] [Related]
32. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53.
Tishler RB; Lamppu DM; Park S; Price BD
Cancer Res; 1995 Dec; 55(24):6021-5. PubMed ID: 8521385
[TBL] [Abstract][Full Text] [Related]
33. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
[TBL] [Abstract][Full Text] [Related]
34. DNA damage-induced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1.
Tamura T; Ishihara M; Lamphier MS; Tanaka N; Oishi I; Aizawa S; Matsuyama T; Mak TW; Taki S; Taniguchi T
Leukemia; 1997 Apr; 11 Suppl 3():439-40. PubMed ID: 9209417
[TBL] [Abstract][Full Text] [Related]
35. Altered DNA repair and dysregulation of p53 in IRF-1 null hepatocytes.
Prost S; Bellamy CO; Cunningham DS; Harrison DJ
FASEB J; 1998 Feb; 12(2):181-8. PubMed ID: 9472983
[TBL] [Abstract][Full Text] [Related]
36. Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2.
Coccia EM; Del Russo N; Stellacci E; Orsatti R; Benedetti E; Marziali G; Hiscott J; Battistini A
Oncogene; 1999 Mar; 18(12):2129-37. PubMed ID: 10321737
[TBL] [Abstract][Full Text] [Related]
37. Cell-cycle control and its watchman.
Jacks T; Weinberg RA
Nature; 1996 Jun; 381(6584):643-4. PubMed ID: 8649505
[No Abstract] [Full Text] [Related]
38. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod KF; Sherry N; Hannon G; Beach D; Tokino T; Kinzler K; Vogelstein B; Jacks T
Genes Dev; 1995 Apr; 9(8):935-44. PubMed ID: 7774811
[TBL] [Abstract][Full Text] [Related]
39. Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence.
Krones-Herzig A; Adamson E; Mercola D
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3233-8. PubMed ID: 12629205
[TBL] [Abstract][Full Text] [Related]
40. Tumour-suppressor genes. Killer in search of a motive?
Clurman B; Groudine M
Nature; 1997 Sep; 389(6647):122-3. PubMed ID: 9296483
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
